Degree of hepatic dysfunction and improvement of renal function predict survival in patients with HRS type I: A retrospective analysis

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 12, 2009, Pages 1428-1432

  Appenrodt, Beate ^a   Zielinski, Julia ^a   Brensing, Karl August ^a   Heller, Jörg ^a   Sauerbruch, Tilman ^a   Schepke, Michael ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Hepatorenal syndrome type I; Liver cirrhosis; Terlipressin; TIPS

Indexed keywords

CREATININE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATORENAL SYNDROME; HUMAN; KIDNEY FUNCTION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TREATMENT RESPONSE;

ADULT; BIOLOGICAL MARKERS; CREATININE; EPIDEMIOLOGIC METHODS; FEMALE; HEPATORENAL SYNDROME; HUMANS; KIDNEY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROGNOSIS; TREATMENT OUTCOME;

EID: 77950255757     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32832ec16a     Document Type: Article

References (14)

1. Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentium P, Laffi G, Reynolds TB. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome. Hepatology 1996; 23: 164-176.
2. Salerno F, Gerbes AL, Gines P, Wong F, Arroyo V. Definition and diagnosis and prevention and treatment of hepatorenal syndrome in cirrhosis. A consensus workshop of the International Ascites Club. Gut 2007; 56: 1310-1318.
3. Gines A, Escorsell A, Gines P, Salo J, Jimenez W, Inglada L, Navasa M. Incidence, predictive factors and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993; 105: 229-236.
4. Gonwa TA, Goldstein M, Holman M, Husberg BS, Klintmalm GB. Orthotopic liver transplantation and renal function: outcome of hepatorenal syndrome and trial or verapamil for renal protection in nonhepatorenal syndrome. Transplant Proc 1993; 25: 1891-1892.
5. Moreau R, Durand F, Poynard T, Duhamel C, Cervoni JP, lchai P. Terlipressin in patients with cirrhosis and type I hepatorenal syndrome: a retrospective multicenter study. Gastroenterology 2002; 122: 923-930.
6. Sanyal AJ, Boyer T, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 2008; 134: 1360-1368.
7. Martin-Llahi M, Pepin MN, Guevara M, Diaz F, Torre A, Monescillo A, et al. Terlipressin and albumin vs. albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology 2008; 134: 1352-1359.
8. Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, et al. Improvement of hepatorenal syndrome with extracorporal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000; 6: 287-289.
9. Keller F, Heinze H, Jochimsen F, Paßfall J, Schuppan D, Büttner P. Risk factors and outcome of 107 patients with decompensated liver disease and acute renal failure (including 26 patients with hepatorenal syndrome): the role of hemodialysis. Ren Fail 1995; 17: 135-146.
10. Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, et al. Long-term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhosis with hepatorenal syndrome: a phase-II study. Gut 2000; 47: 288-295.
11. Guevara M, Gines P, Bandi JC, Gilabert R, Sort P, Jimenez W. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 1998; 28: 416-422.
12. Brensing KA, Raab P, Textor J, Görich J, Schiedermaier P, Strunk H, et al. Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt: Bonn TIPSS early mortality analysis. Eur J Gastroenterol Hepatol 2002; 14: 723-731.
13. Quick AJ, Stanley-Brown M, Bancroft FW. A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci 1935; 190: 501-511.
14. Salerno F, Cammà C, Enea M, Rössle M, Wong F. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology 2007; 133: 825-834.